ACTINIUM PHARMACEUTICALS, INC. (ATNM) Return on equity 2021–2025
ACTINIUM PHARMACEUTICALS, INC. (ATNM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-432.6%FY2025 · since FY2021: -33.7% → -432.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -432.6% | — |
| FY2023 | -134.2% | -84.5 pp |
| FY2022 | -49.7% | -16.0 pp |
| FY2021 | -33.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice